AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $956 | -55.0% | 13,686 | -53.7% | 0.10% | -41.4% |
| Q2 2023 | $2,126 | +468.4% | 29,579 | +387.2% | 0.16% | +305.0% |
| Q1 2023 | $374 | -99.9% | 6,071 | -35.9% | 0.04% | +2.6% |
| Q3 2022 | $422,000 | +31.9% | 9,466 | +13.3% | 0.04% | +44.4% |
| Q2 2022 | $320,000 | -52.2% | 8,355 | -58.8% | 0.03% | -54.2% |
| Q3 2021 | $669,000 | +99.1% | 20,292 | +241.6% | 0.06% | +145.8% |
| Q1 2021 | $336,000 | -61.7% | 5,940 | -51.8% | 0.02% | -84.1% |
| Q3 2020 | $878,000 | +78.5% | 12,320 | +105.9% | 0.15% | +164.9% |
| Q2 2020 | $492,000 | +720.0% | 5,984 | -67.8% | 0.06% | +1800.0% |
| Q2 2018 | $60,000 | – | 18,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |